caprylates has been researched along with Bowel Diseases, Inflammatory in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braga, LLBC; Cavalcanti, RF; de Castro, M; Nobre E Souza, MA; Oliveira, RB; Sales, KMO; Saraiva, LGM; Souza, MHLP | 1 |
Arijs, I; De Preter, V; Joossens, M; Machiels, K; Matthys, C; Rutgeerts, P; Verbeke, K; Vermeire, S | 1 |
Kandula, M; Palanichamy, S; Rampal, A; Sunil Kumar, KB | 1 |
3 other study(ies) available for caprylates and Bowel Diseases, Inflammatory
Article | Year |
---|---|
Gastroduodenal Symptoms in Inflammatory Bowel Disease Are Correlated with Gastric Emptying and Serum Levels of Active Ghrelin.
Topics: Adult; Aged; Breath Tests; Caprylates; Carbon Isotopes; Case-Control Studies; Duodenum; Female; Gastric Emptying; Ghrelin; Humans; Inflammatory Bowel Diseases; Leptin; Male; Middle Aged; Stomach | 2019 |
Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
Topics: Adolescent; Adult; Aged; Caproates; Caprylates; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Fatty Acids; Feces; Female; Humans; Inflammatory Bowel Diseases; Male; Microbiota; Middle Aged; Pouchitis; Sensitivity and Specificity; Valerates; Young Adult | 2015 |
Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Topics: Aminosalicylic Acids; Animals; Caprylates; Colitis; Colon; Dextran Sulfate; Drug Discovery; Drug Evaluation, Preclinical; Eicosapentaenoic Acid; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Mice; Mice, Inbred C57BL; Prodrugs; Rats; Rats, Sprague-Dawley; Sulfasalazine | 2016 |